| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.7 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |